Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

The systemic effect of cancers on human sera proton NMR relaxation times.

Beall PT, Narayana PA, Amtey SR, Spiga L, Intra E, Ridella S, Mela GS.

Magn Reson Imaging. 1984;2(2):83-7.

PMID:
6085132
2.

Presence of a unique serum protein in sera obtained from patients with neoplastic diseases and in embryonic and neonatal sera.

Takahashi A, Yachi A, Anzai T, Wada T.

Clin Chim Acta. 1967 Jul;17(1):5-12. No abstract available.

PMID:
4166654
3.

Similarity between leukocyte cultures from cancerous and noncancerous human subjects: an electron microscopic study.

Chandra S, Moore GE, Brandt PM.

Cancer Res. 1968 Oct;28(10):1982-9. No abstract available.

4.
5.

Serum phospholipids in neoplastic disorders.

Lee LM.

Clin Chim Acta. 1971 Mar;32(1):25-32. No abstract available.

PMID:
4328879
6.

Nuclear magnetic resonance study of cancer: systemic effect on the proton relaxation times (T1 and T2) of human serum.

de Certaines J, Bernard AM, Benoist L, Rivet P, Gallier J, Morin P.

Cancer Detect Prev. 1981;4(1-4):267-71.

PMID:
7349785
7.

[Cytochemical study of lactic acid in leukemia cells].

Piette M, Durand G.

Nouv Rev Fr Hematol. 1969 Sep-Oct;9(5):688-96. French. No abstract available.

PMID:
4313092
8.

Distinction between normal and leukemic bone marrow by water protons nuclear magnetic resonance relaxation times.

Shah S, Ranade SS, Kasturi SR, Phadke RS, Advani SH.

Magn Reson Imaging. 1982;1(1):23-8.

PMID:
6965035
9.

Serum vitamin B 12 and vitamin B 12 binding capacity in chronic myelogenous leukemia and other disorders.

Rosner F, Schreiber ZA.

Am J Med Sci. 1972 Jun;263(6):473-80. No abstract available.

PMID:
4505888
10.

Proton NMR relaxation times in the peripheral blood of cancer patients.

Ekstrand KE, Dixon RL, Raben M, Ferree CR.

Phys Med Biol. 1977 Sep;22(5):925-31.

PMID:
561969
11.

Pulsed nuclear magnetic resonance studies of human bone marrow.

Ranade SS, Shah S, Advani SH, Kasturi SR.

Physiol Chem Phys. 1977;9(3):297-9.

PMID:
271308
12.

Serum ferritin levels in hematologic malignant neoplasms.

Patel AR, Shah PC, Vohra RM, Hart WL, Shah JR.

Arch Pathol Lab Med. 1980 Oct;104(10):509-12.

PMID:
6932189
13.

High-molecular-weight hydroxyproline-protein in relation to immunoglobulins M (IgM) in human blood serum.

Tomaszewski J, Kowalewski J.

Clin Chim Acta. 1975 Apr 16;60(2):185-9.

PMID:
47792
14.

[Serum determination of CA 19-9 in patients with digestive cancers and its diagnostic evaluation].

Arakawa Y, Kobayashi H, Ozaki T, Ariga H, Matsuo Y, Honda T, Arai T, Kurosu Y, Morita K, Konuma H, et al.

Gan To Kagaku Ryoho. 1984 Apr;11(4):917-25. Japanese.

PMID:
6586110
15.

Antiserum against leukemia cell ferritin as a diagnostic tool for malignant neoplasms.

Mori W, Asakawa H, Taguchi T.

J Natl Cancer Inst. 1975 Sep;55(3):513-8.

PMID:
1057655
16.

The content of erythrocyte 2,3 diphosphoglycerate and adenosine-5'-triphosphate in myelomatosis and leukaemia.

Hjelm M, Udén AM, Engstedt L.

Scand J Haematol. 1976 Jan;16(1):48-55.

PMID:
1082630
17.

Beta-2-microglobulin review: its relevance in clinical oncology.

Cooper EH, Plesner T.

Med Pediatr Oncol. 1980;8(4):323-34. Review.

PMID:
6161299
18.

The spin-lattice relaxation time in the blood of healthy subjects and patients with malignant blood disease.

Koivula A, Suominen K, Timonen T, Kiviniitty K.

Phys Med Biol. 1982 Jul;27(7):937-47.

PMID:
7111398
19.

Activation of host lymphocytes cultured with cancer cells treated with neuraminidase.

Watkins E Jr, Ogata Y, Anderson LL, Watkins E 3rd, Waters MF.

Nat New Biol. 1971 May 19;231(20):83-5. No abstract available.

PMID:
4325655
20.
Items per page

Supplemental Content

Write to the Help Desk